ARGONAUT THERAPEUTICS LIMITED Trademark of Argonaut Therapeutics Limited - Serial Number 90072083

ARGONAUT THERAPEUTICS LIMITED Trademark

Trademark Overview

On Friday, July 24, 2020, a trademark application was filed for ARGONAUT THERAPEUTICS LIMITED with the United States Patent and Trademark Office. The USPTO has given the ARGONAUT THERAPEUTICS LIMITED trademark a serial number of 90072083. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, July 7, 2021. This trademark is owned by Argonaut Therapeutics Limited. The ARGONAUT THERAPEUTICS LIMITED trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer

Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; r...

General Information

Serial Number	90072083
Word Mark	ARGONAUT THERAPEUTICS LIMITED
Filing Date	Friday, July 24, 2020
Status	661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status Date	Wednesday, July 7, 2021
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Description of Mark	The mark consists of a series of concentric circles of various sizes inside a larger circle.
Goods and Services	Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer
Goods and Services	Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Monday, August 24, 2020
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Monday, August 24, 2020
Primary Code	042
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Argonaut Therapeutics Limited
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	Oxford OX44GA GB

Trademark Events

Event Date	Event Description
Thursday, August 12, 2021	ASSIGNED TO EXAMINER
Wednesday, July 7, 2021	TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 7, 2021	CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 7, 2021	ASSIGNED TO LIE
Monday, May 17, 2021	TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 17, 2020	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 17, 2020	NON-FINAL ACTION E-MAILED
Tuesday, November 17, 2020	NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020	ASSIGNED TO EXAMINER
Tuesday, August 25, 2020	NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, August 24, 2020	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 28, 2020	NEW APPLICATION ENTERED IN TRAM

Related Keywords

limited therapeutics argonaut cancer treatment development research pharmaceutical prevention vaccines arginine field detection